S, G., J, L., H, Z., & X, W. (2026). Nipple aspirate fluid as a proximal breast liquid biopsy platform: Advancing precision risk management in breast cancer. Clinical proteomics, 23(1), . https://doi.org/10.1186/s12014-026-09612-5
Chicago Style (17th ed.) CitationS, Guo, Liu J, Zheng H, and Wu X. "Nipple Aspirate Fluid as A proximal Breast Liquid Biopsy Platform: Advancing Precision Risk Management in Breast Cancer." Clinical Proteomics 23, no. 1 (2026). https://doi.org/10.1186/s12014-026-09612-5.
MLA (9th ed.) CitationS, Guo, et al. "Nipple Aspirate Fluid as A proximal Breast Liquid Biopsy Platform: Advancing Precision Risk Management in Breast Cancer." Clinical Proteomics, vol. 23, no. 1, 2026, https://doi.org/10.1186/s12014-026-09612-5.